BioSpace News Archive

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated results and new translational research data from two phase 1 studies evaluating investigational antibody drug conjugates (ADCs) U3-1402 and DS-1062 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) will be presented at the 2019 IASLC World Conference on Lung Cancer (#WCLC19), to be held September 7-10, 2019 in Barcelona, Spain.

LC GC®, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences, will host three webcasts in August.

The global Hemophilia A therapeutics market size is poised to grow by USD 4.31 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 7% during the forecast period.

Laerdal Medical achieves a breakthrough in service by providing clients access to an all new how-to video library

DataPath, Inc., a leading provider of technology solutions for healthcare benefits administration, announced today an affiliation with TPA Stream, a middleware software for healthcare and financial services

The American Foundation for the Blind (AFB) has received a $100,000 grant from American Express to launch the Blind Leaders Development Program, specifically targeted at blind and low vision people who are already employed and in the beginning stages of their careers.

Through the Innovation Superclusters Initiative, the Government of Canada is taking immediate and targeted action to build on Canada’s existing strengths to help our companies and their workers get ahead in the global innovation race

Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors.

Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced its conference schedule for September 2019.

Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019.